SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Genesys (CEGE)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Timoteo who wrote (697)2/27/2000 8:04:00 PM
From: david james  Read Replies (1) of 1298
 
Some things from Yahoo

recap.com

Click "Search Companies"
Type in Cell Genysys
Click "clinicals"

I see they still mention melanoma as late as mid 1999

ims-global.com

My only guess is that they decided that since there are other relatively successful techniques for dealing with melanoma, gene therapy was considered to involve a bit too much risk at this time?

The evidence against this explanation comes from this interesting set of CEGE results for prostate cancer.

quad-net.com
____________________________
"The gene we used to turn on the immune system is so good that it activates everything," says William G. Nelson, M.D., Ph.D. "We were not surprised to see T-cell activation, the arm of the immune system triggered by viruses, but this vaccine also stimulated new high-level antibody production. Such a complete and thorough activation of the immune system against prostate cancer has never before been seen," he says.
.........
In fact, the therapy is so well tolerated by patients that no hospitalization is required. The only side effects associated with this therapy are flulike symptoms and redness and itchiness at the vaccine site for several days.

____________________________________
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext